Lupin looks to launch 25 products in US this fiscal
In the current year, apart from the Gavis portfolio, Fortamet and Glumetza, the company expects to launch products like Minastrin and Epzicom.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Abacavir Sulfate and Lamivudine | Biotechnology | Epzicom | Fortamet | Metformin | Pharmaceuticals